Newmed Energy Limited Partnership (IL:NWMD)
TASE:NWMD
Want to see IL:NWMD full AI Analyst Report?
Top Page
Newmed Energ Pu
(TASE:NWMD)
Select Model
Select Model
Rating:68Neutral
Price Target:
1,962.00
▲(2.45% Upside)
Action:Reiterated
Date:05/22/26
The score is driven primarily by strong profitability, solid operating cash flow, and improved leverage, offset by weakening top-line/earnings and softer free-cash-flow trends. Technical indicators remain weak (negative MACD and price below key moving averages), while valuation is supported by a moderate P/E and a ~3.7% dividend yield.
Positive Factors
High profitability margins
Very high TTM gross (~55%) and net (~35%) margins indicate structural cost advantages or favorable contract pricing. Durable margins support operating profitability, provide a buffer versus commodity swings, and underpin the capacity to fund capex, exploration and partner distributions over coming quarters.
Negative Factors
Revenue decline / choppy top line
A ~-12.6% TTM revenue decline and a choppy top-line across recent years signal volume or pricing headwinds. Prolonged top-line weakness reduces scale benefits, constrains reinvestment for reserves development or exports, and forces greater reliance on margin preservation to sustain earnings.
Read all positive and negative factors
Positive Factors
Negative Factors
High profitability margins
Very high TTM gross (~55%) and net (~35%) margins indicate structural cost advantages or favorable contract pricing. Durable margins support operating profitability, provide a buffer versus commodity swings, and underpin the capacity to fund capex, exploration and partner distributions over coming quarters.
Read all positive factors
Newmed Energ Pu (NWMD) vs. iShares MSCI Israel ETF (EIS)
Market Cap
₪18.91B
Dividend Yield3.95%
Average Volume (3M)1.02M
Price to Earnings (P/E)28.6
Beta (1Y)1.25
Revenue Growth-30.64%
EPS Growth-59.45%
CountryIL
Employees23
SectorEnergy
Sector Strength52
IndustryOil & Gas Exploration & Production
Share Statistics
EPS (TTM)0.19
Shares Outstanding1,173,814,700
10 Day Avg. Volume836,117
30 Day Avg. Volume1,024,307
Financial Highlights & Ratios
PEG Ratio-0.62
Price to Book (P/B)3.51
Price to Sales (P/S)7.08
P/FCF Ratio21.80
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.48
Revenue Forecast (FY)₪1.04B
Newmed Energ Pu Business Overview & Revenue Model
Company Description
NewMed Energy - Limited Partnership is an energy firm engaged in the exploration, development, production, and commercialization of petroleum, natural gas, and condensate, primarily operating in Israel and Cyprus. The company holds significant int...
How the Company Makes Money
NewMed Energy primarily makes money from the sale of natural gas produced from the upstream assets in which it holds interests. Revenue is generated by delivering contracted volumes of gas to customers (e.g., power producers, industrial users, and...
Newmed Energ Pu Financial Statement Overview
Summary
Income Statement
78
Positive
Balance Sheet
70
Positive
Cash Flow
73
Positive
| Breakdown | TTM | Dec 2025 | Dec 2024 | Mar 2024 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 857.20M | 938.07M | 1.14B | 934.60M | 1.14B | 882.50M |
| Gross Profit | 367.94M | 585.08M | 718.10M | 780.70M | 701.70M | 518.11M |
| EBITDA | 663.27M | 760.65M | 874.80M | 782.70M | 872.10M | 657.20M |
| Net Income | 227.05M | 371.29M | 524.60M | 433.60M | 469.70M | 404.90M |
Balance Sheet | ||||||
| Total Assets | 4.05B | 3.97B | 3.99B | 3.85B | 3.94B | 3.85B |
| Cash, Cash Equivalents and Short-Term Investments | 213.40M | 157.53M | 384.50M | 186.70M | 418.30M | 340.85M |
| Total Debt | 1.53B | 1.12B | 1.63B | 1.82B | 2.16B | 2.22B |
| Total Liabilities | 2.23B | 2.08B | 2.21B | 2.33B | 2.65B | 2.91B |
| Stockholders Equity | 1.82B | 1.89B | 1.79B | 1.51B | 1.29B | 938.54M |
Cash Flow | ||||||
| Free Cash Flow | 222.71M | 304.72M | 463.30M | 423.10M | 405.80M | 423.25M |
| Operating Cash Flow | 493.73M | 547.08M | 577.50M | 559.50M | 504.70M | 453.64M |
| Investing Cash Flow | -143.48M | 30.20M | -114.20M | 36.10M | -273.50M | 982.04M |
| Financing Cash Flow | -312.88M | -516.12M | -441.20M | -588.90M | -429.10M | -1.29B |
Newmed Energ Pu Technical Analysis
Negative
1915.00
Price Trends
1784.26
Negative
1876.65
Negative
1761.14
Negative
Market Momentum
-43.97
Negative
37.84
Neutral
48.41
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IL:NWMD, the sentiment is Negative. The current price of 1915 is above the 20-day moving average (MA) of 1686.96, above the 50-day MA of 1784.26, and above the 200-day MA of 1761.14, indicating a bearish trend. The MACD of -43.97 indicates Negative momentum. The RSI at 37.84 is Neutral, neither overbought nor oversold. The STOCH value of 48.41 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IL:NWMD.
Newmed Energ Pu Peers Comparison
UnderperformOutperform
Sector (65)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
69 Neutral | ₪1.91B | 16.85 | ― | 7.38% | -13.14% | -26.30% | |
68 Neutral | ₪18.91B | 28.55 | 24.33% | 3.95% | -30.64% | -59.45% | |
65 Neutral | $15.17B | 7.61 | 4.09% | 5.20% | 3.87% | -62.32% | |
61 Neutral | ₪14.87B | 4.52 | 4.49% | 6.64% | -27.59% | 190.27% | |
59 Neutral | ₪352.42M | 20.61 | ― | 5.36% | -0.66% | 118.76% | |
59 Neutral | ₪14.24B | 29.68 | ― | ― | 584.71% | 855.02% |
* Energy Sector Average
IL:NWMD
Newmed Energ Pu
1,670.00
246.29
17.30%
IL:DLEKG
Delek Group
83,710.00
21,837.98
35.30%
IL:ISRA
Isramco Pu
197.50
-15.80
-7.41%
IL:TOEN
Tomer Energy
1,788.00
-393.32
-18.03%
IL:TMRP
Tamar Pet
2,541.00
-741.11
-22.58%
IL:NVPT
Navitas Ptro Pu
12,130.00
1,957.11
19.24%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.